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Abstract
Objectives: Anorexia nervosa is a severe psychiatric disorder with high mortality rates. While its aetiology is poorly 
understood, there is evidence of a significant genetic component. The Anorexia Nervosa Genetics Initiative is an inter-
national collaboration which aims to understand the genetic basis of the disorder. This paper describes the recruitment 
and characteristics of the Australasian Anorexia Nervosa Genetics Initiative sample, the largest sample of individuals with 
anorexia nervosa ever assembled across Australia and New Zealand.
Methods: Participants completed an online questionnaire based on the Structured Clinical Interview Diagnostic and Sta-
tistical Manual of Mental Disorders (4th ed.; DSM-IV) eating disorders section. Participants who met specified case criteria 
for lifetime anorexia nervosa were requested to provide a DNA sample for genetic analysis.
Results: Overall, the study recruited 3414 Australians and 543 New Zealanders meeting the lifetime anorexia nervosa 
case criteria by using a variety of conventional and social media recruitment methods. At the time of questionnaire 
completion, 28% had a body mass index ⩽ 18.5 kg/m2. Fasting and exercise were the most commonly employed  methods 
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Anorexia nervosa (AN) imposes a major health burden in 
Australasia and worldwide, and has a higher mortality rate 
than any other psychiatric disorder (Deloitte Access 
Economics, 2012). Community-based estimates of inci-
dence and lifetime prevalence vary between countries, and 
are affected by variations in definitions of AN and statisti-
cal power limitations (Smink et al., 2012). An Australian 
study of female twins has estimated the lifetime prevalence 
of AN (using Diagnostic and Statistical Manual of Mental 
Disorders [4th ed.; DSM-IV] criteria (American Psychiatric 
Association, 1994)) at 1.9%, with a further 2.4% meeting 
all criteria except amenorrhoea (Wade et al., 2006). The 
lifetime prevalence of AN (using DSM-IV criteria) in New 
Zealand women has been estimated at 1.0%, and in New 
Zealand men at 0.1% (Oakley Browne et al., 2006). The 
causes of AN are still largely unknown; however, twin stud-
ies have estimated its heritability to be around 60% (Bulik 
et al., 2006; Wade et al., 1999, 2000), intermediate between 
depression (~40%) (Flint and Kendler, 2014) and schizo-
phrenia (~80%) (Sullivan et al., 2003).
Genome-wide association studies (GWAS) have recently 
been shown to be an effective method of finding genes for 
some psychiatric disorders, including schizophrenia, autism 
and bipolar disorder, where very large samples of cases and 
controls (36,989 cases, 113,075 controls in the case of schiz-
ophrenia) have identified multiple loci meeting genome-
wide significance (Cross-Disorder Group of the Psychiatric 
Genomics Consortium, 2013; Schizophrenia Working 
Group of the Psychiatric Genomics Consortium, 2014). A 
GWAS conducted on 1033 AN cases and 3773 paediatric 
controls in the United States found a number of association 
signals that the authors deemed worthy of follow-up, includ-
ing near ZNF804B, CSRP2BP, NTNG1, AKAP6 and CDH9, 
but none that met genome-wide association significance 
(Wang et al., 2011). Pilot genome-wide association analyses 
in a sample of 2564 female twins conducted in Australia 
(Wade et al., 2013) identified six genomic regions with sug-
gestive significance for eating disorders, including four for 
AN: near the CLEC5A, LOC136242, TSHZ1, and SYTL5 
loci (p < 5 × 10−7). Both studies concluded that much larger 
samples were needed to identify genes for eating disorders 
at a genome-wide significance level of p < 5 × 10−8. In 2014, 
an international consortium performed GWAS on AN 
patients from 17 countries. Despite recruiting 2907 AN 
cases and 14,860 controls, no findings reached genome-
wide significance (Boraska et al., 2014) and the authors con-
cluded that this sample, although the largest yet reported, 
was still underpowered.
Thus, there is an urgent need to collect much larger sam-
ples of genotyped AN cases and controls if we are to con-
vincingly elucidate the genetic basis of AN. The Anorexia 
Nervosa Genetics Initiative (ANGI) is an international col-
laboration which aimed to collect diagnostic data and blood 
samples from over 13,000 individuals with AN in Australia, 
the United States, Sweden and Denmark. The purpose of 
this paper is to report on the methods of recruitment used 
by the Australian site and describe the features and treat-
ment experiences of a large community sample of people 
with AN in Australia and New Zealand. This is the largest 
sample of people with lifetime AN collected in Australasia 
to date, and these results will improve our understanding of 
the care of patients with AN, as well as inform research that 




Participants for this study were Australian and New Zealand 
women and men who self-reported having had AN at any 
point in their lifetime. Prospective participants under the 
age of 18 were recruited only if parental permission was 
obtained. Recruitment was conducted from May 2013 to 
July 2016 by public appeal through networks from profes-
sional organisations (e.g. Australia and New Zealand 
of weight control, and were associated with the youngest reported ages of onset. At the time of the study, 32% of partici-
pants meeting lifetime anorexia nervosa case criteria were under the care of a medical practitioner; those with current 
body mass index < 18.5 kg/m2 were more likely to be currently receiving medical care (56%) than those with current 
body mass index ⩾ 18.5 kg/m2 (23%). Professional treatment for eating disorders was most likely to have been received 
from general practitioners (45% of study participants), dietitians (42%) and outpatient programmes (42%).
Conclusions: This study was effective in assembling the largest community sample of people with lifetime anorexia ner-
vosa in Australia and New Zealand to date. The proportion of people with anorexia nervosa currently receiving medical 
care, and the most common sources of treatment accessed, indicates the importance of training for general practitioners 
and dietitians in treating anorexia nervosa.
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Academy for Eating Disorders), press conferences, con-
ventional media (newspaper, radio and television), promo-
tional materials distributed through eating disorder clinics, 
mailouts to discharged hospital patients who had a diagno-
sis of AN, conferences and support groups, social media 
(Facebook, Twitter and blogs) and word-of-mouth. These 
were supported on several occasions by public relations 
campaigns, either nationally or in targeted geographic 
areas, and public lectures. These recruitment methods were 
not designed to generate a population cohort that is either 
random or population-based, as these are not requirements 
for GWAS. Rather, they were designed to preferentially 
attract prospective participants to the study who are most 
likely to meet case criteria.
Instrument
The online questionnaire used was adapted from the 
Structured Clinical Interview for DSM-IV, section H 
Eating Disorders (SCID-H for Diagnostic and Statistical 
Manual of Mental Disorders [4th ed., text rev.; DSM-
IV-TR]) (First et al., 2002). A total of 65 items were 
included in the questionnaire, but as this was branched, 
not all participants answered all items. The initial items 
focussed around case criteria, as outlined in Table 1. Other 
items concerned binge-eating behaviours, methods of 
weight control and the presence of amenorrhoea during 
episodes of low weight. Amenorrhoea is not a diagnostic 
criterion for AN under Diagnostic and Statistical Manual 
of Mental Disorders, Fifth Edition (DSM-5) (American 
Psychiatric Association, 2013) and was not required for 
participation in the study. The final section of the ques-
tionnaire included extra items not adapted from SCID-H, 
regarding medical care and treatment for the participant’s 
eating disorder, and how the participant was recruited to 
the study. Ancestry data were requested from all partici-
pants meeting AN case criteria. Six ancestry categories 
were provided for response (European, Middle Eastern, 
Asian, African, Pacific Islander, South American), with 
participants able to provide up to two ancestries for each 
grandparent.
Data collection
Participants were invited to access the study website for 
their country and complete the online questionnaire. In 
Australia, individuals meeting the criteria specified in Table 
1 were then invited by email to provide a blood sample. A 
blood collection kit, containing 3 × 10 mL blood collection 
tubes with ethylenediamine tetraacetic acid (EDTA) antico-
agulant, was sent to the participant. Study personnel con-
tacted participants by telephone and/or email to facilitate 
and track the blood collection process through local pathol-
ogy clinics. Blood samples collected at the pathology clinic 
were couriered within 48 hours to the laboratory using pre-
paid satchels included in the collection kit. In New Zealand, 
eligible participants were contacted and face-to-face or 
video-call meetings were arranged to go through the study 
and to obtain witnessed consent. Once consent forms were 
returned, participants were posted blood kits which they 
took to their local phlebotomy laboratory for sample collec-
tion. An existing New Zealand-wide laboratory collection 
courier system was utilised to return the chilled samples to 
Christchurch where they were frozen, before shipping in 
batches to Australia.
Of the three 10 mL EDTA tubes collected per partici-
pant, two were de-identified and sent as frozen whole blood 
to the Rutgers University Cell and DNA Repository 
(RUCDR) in the United States, with the remainder pro-
cessed and stored locally. For a small number of Australian 
study participants unwilling or unable to provide a blood 
sample, a saliva sampling kit was posted to them for return 
by pre-paid post.
Since the relative effectiveness of a range of participant 
recruitment methods was of interest in this study, particular 
attention was paid to the categorisation of information 
sources nominated by participants as being involved in 
their recruitment. Participants were classified as having 
been recruited by ‘online news’ if they provided a text-
based response to the questionnaire item ‘How did you find 
out about this study?’ that included the term ‘online news’ 
or nominated a particular online news website. Similarly, 
responses were classified as ‘social media’ if they refer-
enced Facebook, Twitter, blogs, LinkedIn or Tumblr. More 
generic responses such as ‘internet’, ‘online’, ‘website’ and 
‘email’ were classified as ‘other online sources’. Similarly, 
participants who indicated that their recruitment occurred 
via an eating disorders interest or support group (e.g. 
Butterfly Foundation, Eating Disorders Association of New 
Zealand [EDANZ]) or eating disorders conference had 
their responses coded as ‘interest/support group’ and ‘con-
ference’ respectively.
Data analysis
Data analysis for this study was performed using SPSS 
Statistics 22.0.0.0 (IBM Corporation, Armonk, New York) 
Table 1. Criteria required to qualify as AN case.a
A. BMI ⩽ 18.5 kg/m2
B. Fear of gaining weight or being fat
C. Any one of
1. Disturbance in experience of weight or shape
2. Undue influence of weight or shape on self-evaluation
3. Denial of seriousness of low weight
AN: anorexia nervosa; BMI: body mass index.
aCriterion A is essential. If data pertaining to either one of Criterion B or 
C are missing but both other criteria are fulfilled, subject qualifies as case.
and Excel 2010 14.0.7166.5000 (Microsoft Corporation, 
Redmond, Washington).
Research ethics and participant consent
All participants provided informed written consent, includ-
ing consent for publication of de-identified study results. 
For Australian participants, written consent was via online 
submission. Prospective participants younger than 18 years 
of age then completed a paper questionnaire which required 
co-signature by a parent/guardian. New Zealand partici-
pants completed a paper-based consent form, which for 
prospective participants under 18 years of age required par-
ent/guardian co-signature. Ethical approval for the 
Australian component of the study was provided by the 
QIMR Berghofer Human Research Ethics Committee. 
Ethical approval for the New Zealand component of the 
study was provided by the Health and Disability Ethics 
Committee of the New Zealand Ministry of Health.
Results
Participants meeting lifetime AN case 
criteria
Lifetime AN case criteria (Table 1) were met by 3414 
Australian participants (average age 32 years; standard 
deviation [SD] = 13 years) and 543 New Zealand partici-
pants (average age 34 years; SD = 14 years). A total of 
3348 Australian participants and 537 New Zealand partici-
pants met all three case criteria. A further 66 Australian 
participants and six New Zealand participants qualified as 
cases although they had missing data for criterion B (fear 
of gaining weight), but qualified for criteria A (body mass 
index [BMI] ⩽ 18.5 kg/m2) and C (disturbance in experi-
ence of weight or shape, undue influence or weight or 
shape on self-evaluation, denial of seriousness of low 
weight). No participants qualified as cases with missing 
data for criterion C.
The majority of study participants meeting lifetime AN 
case criteria came from New South Wales, followed by 
Victoria, Queensland, New Zealand, Western Australia, 
South Australia, Australian Capital Territory, Tasmania and 
Northern Territory. The highest lifetime AN case study 
recruitment rates (per 100,000 population) were observed 
in Australian Capital Territory, Queensland and Tasmania 
(Figure 1).
The average BMI at the time of the questionnaire was 
20.3 kg/m2 (SD = 3.7 kg/m2) for Australian participants 
meeting lifetime AN case criteria, and 20.9 kg/m2 (SD = 3.7 
kg/m2) for New Zealand participants meeting lifetime AN 
case criteria. The average lowest adult BMI for participants 
meeting lifetime AN case criteria was 16.6 kg/m2 (SD = 3.4 
kg/m2) for Australian participants, and 14.9 kg/m2 (SD = 2.0 
kg/m2) for New Zealand participants. Other characteristics 
of participants meeting lifetime AN case criteria from each 
country are shown in Table 2. Figure 2 shows the distribu-
tion of AN severity for participants meeting lifetime AN 
case criteria as adults, according to DSM-5 criteria based on 
lowest BMI since age 18 (American Psychiatric Association, 
2013) (mild is over 17 kg/m2, moderate is 16–16.99 kg/m2, 
severe is 15–15.99 kg/m2, extreme is lower than 15 kg/m2). 
Figure 1. ANGI study registration rate per 100,000 population. Population estimates as of March 2016 for Australia 
(Australian Bureau of Statistics, 2016a) and June 2016 for New Zealand (Statistics New Zealand, 2016b).
On average, New Zealand participants meeting lifetime AN 
case criteria had lower minimum adult BMI than Australian 
participants meeting these criteria (χ3
2 = 47 6. , p < 0.001).
Methods of recruitment
Participants who completed the questionnaire were asked 
to report how they heard about the study, and were invited 
to select as many options as applied to them. Figure 3 
shows the percentage of study recruitment nominations for 
each method by age group for people meeting lifetime AN 
case criteria for each country. Considerable variation 
existed across age groups; e.g., social media was most 
effective in recruiting the 18- to 24-year age group, whereas 
broadcast and print media were common in the 40 years 
and over age group. For the participants who endorsed 
‘friend/family member’ or ‘doctor or other medical practi-
tioner’ as a source of information about the study, it is not 
possible to determine the primary method by which this 
referring individual learned about the study.
Not explicitly shown in Figure 3 is the impact of public 
relations communications to boost study participation num-
bers. Figure 4 demonstrates the overall effectiveness and 
potential national reach of such campaigns, for the Australian 
component of the study only. The public relations cam-
paigns conducted in May 2013, March 2015 and March/
April 2016 were designed to reach the community by 
diverse communication methods, including conventional 
and social media channels. All targeted states and territories 
recorded increased participation immediately afterwards. 
The increase in participation in Queensland in April 2016 
was boosted by a concurrent mailout of information about 
the study by Queensland Health to individuals who had 
been admitted to a Queensland hospital with a diagnosis of 
AN, and who had been discharged between 2007 and 2014.
For the Australian component of the ANGI study, 4638 
people registered on the study website. Study retention 
rates across the various stages of the study (registration, 
questionnaire completion, meeting lifetime AN case crite-
ria and providing a DNA sample) are shown in Figure 5. 
The lowest overall study retention rates were observed for 
the under-18 age group, with the major participation loss 
point being from study registration to questionnaire com-
pletion. The proportion of study participants meeting life-
time AN case criteria who returned DNA samples varied 
significantly by age group. Compared to participants in the 
Figure 2. Severity of anorexia for AN cases using DSM-5 
severity criteria based on lowest BMI since age 18 (AN 
cases ⩾ 18 years only; 2581 Australian participants and 
508 New Zealand participants).
Table 2. Characteristics of Australian and New Zealand study participants meeting lifetime AN case criteria.
Australia (n = 3414) New Zealand (n = 543)
Sex
 Female 3352 (98.1%) 527 (97.1%)
 Male 62 (1.8%) 16 (2.9%)
Age group
<18 years 71 (2.1%) 35 (6.4%)
18–24 years 1217 (35.6%) 156 (28.7%)
25–39 years 1295 (37.9%) 166 (30.6%)
40+ years 831 (24.3%) 186 (34.3%)
Amenorrheic at lowest weighta 2476 (73.9%) 422 (80.1%)
Current BMI ⩽ 18.5 kg/m2 1024 (29.9%) 114 (21.0%)
Currently under care of medical practitioner for an eating disorder 1127 (33.0%) 145 (26.7%)
Ever sought treatment for eating behaviours 2927 (85.7%) 493 (90.8%)
BMI: body mass index.
aWomen only.
40+ age group meeting lifetime AN case criteria (in which 
86% of cases returned DNA samples), participants meeting 
lifetime AN case criteria in the 18–24 age group (odds ratio 
[OR] 0.28, 95% confidence interval [CI]: [0.22, 0.35]) and 
the 25–29 age group (OR 0.44, 95% CI: [0.35, 0.55]) were 
significantly less likely to return DNA samples.
Overall, 2481 Australian participants who met lifetime 
AN case criteria provided a DNA sample (2469 blood sam-
ples, 12 saliva samples), and 543 New Zealand participants 
meeting lifetime AN case criteria provided a blood sample.
Ancestry
Full ancestry information (defined as ancestry informa-
tion for all four grandparents) was provided by 2349 
Australian participants (69%) and 490 New Zealand par-
ticipants (90%) meeting lifetime AN case criteria. Partial 
ancestry information was provided by a further 109 
Australian participants (3.2%) and 15 New Zealand par-
ticipants (2.8%) meeting lifetime AN case criteria. 
Solely European ancestry was reported by 89% of 
Australian and 79% of New Zealand participants meet-
ing lifetime AN case criteria who provided at least par-
tial ancestry information. Other reported ancestry groups 
were Asian (Australia 5.3%, New Zealand 4.1%), Pacific 
Islander (Australia 3.5%, New Zealand 7.7%), Middle 
Eastern (Australia 1.6%, New Zealand 0.9%), South 
American (Australia 0.8%, New Zealand 0.5%) and 
African (Australia 1.0%, New Zealand 0.0%).
Weight control behaviours and binge eating
Figure 6 shows the prevalence of a variety of weight con-
trol behaviours (including exercise, fasting, self-induced 
Figure 3. Recruitment methods nominated by participants meeting lifetime AN case criteria as having provided information 
about the study, by age group, for (a) Australia and (b) New Zealand.
vomiting and the use of diet pills and laxatives/diuretics) 
among individuals meeting lifetime AN criteria. The aver-
age age of onset for use of weight control methods by par-
ticipants meeting lifetime AN case criteria is shown in 
Table 3. Exercise and fasting were the most utilised meth-
ods of weight control across all age groups in both 
countries, and these two methods were generally first 
employed at a younger age than the use of medications and 
self-induced vomiting. There were no differences between 
the Australian (reference group) and New Zealand cohorts 
in ever having used fasting (OR 0.90, 95% CI: [0.63, 1.28]), 
exercise (OR 0.98, 95% CI: [0.56, 1.70]) or self-induced 
Figure 4. Questionnaires completed per state/territory of Australia.
Figure 5. Study phase retention by age group for Australian component of study.
vomiting (OR 0.90, 95% CI: [0.74, 1.08]) as a method of 
weight control. The use of diet pills was less common in 
New Zealand participants (OR 0.74, 95% CI: [0.62, 0.90]), 
while use of laxatives/diuretics was more common in New 
Zealand participants (OR 1.45, 95% CI: [1.21, 1.74]).
There was no observed relationship between method of 
weight control and DSM-5 severity criteria for lowest BMI 
in those over 18 years for Australian participants (fasting: 
χ3
2 = 0 34. , p = 0.95; exercise: χ3
2 = 4 54. , p = 0.21; self-
induced vomiting: χ3
2 = 0 66. , p = 0.88; diet pills: χ3
2 =1 10. ,
p = 0.78; laxatives/diuretics: χ3
2 = 0 50. , p = 0.92) or New
Zealand participants (fasting: χ3
2 =1 73. , p = 0.63; exercise:
χ3
2 = 3 85. , p = 0.28; self-induced vomiting: χ3
2 = 0 15. , p =
0.99; diet pills: χ3
2 = 3 55. , p = 0.32; laxatives/diuretics:
χ3
2 = 9 65. , p = 0.02). Additionally, 60% of Australian and
Figure 6. Prevalence of lifetime use of weight control behaviours among participants meeting AN case criteria in Australia 
(n = 3414) and New Zealand (n = 543).
Table 3. Average ages of onset for weight control behaviours 
for participants meeting lifetime AN criteria.
Method of weight 
control
Average age of onset in years
Australia New Zealand
Exercise 16.6 (SD = 4.7) 16.6 (SD = 4.5)
Fasting 15.7 (SD = 4.2) 15.8 (SD = 4.0)
Self-induced vomiting 17.2 (SD = 4.1) 17.7 (SD = 4.0)
Diet pills 18.7 (SD = 5.0) 18.7 (SD = 4.3)
Laxatives 18.3 (SD = 4.6) 18.8 (SD = 4.4)
Diuretics 19.4 (SD = 5.3) 21.5 (SD = 8.6)
SD: standard deviation.
55% of New Zealand participants meeting lifetime AN case 
criteria reported they had experienced binge eating at some 
time during the course of their illness (average age of onset 
17.8 years, SD = 4.4 years, for Australians; and 17.8 years, 
SD = 4.5 years, for New Zealanders). Self-report rates of 
bulimia nervosa (BN) among Australian and New Zealand 
study participants meeting lifetime AN case criteria were 
38% and 33%, respectively.
Professional medical treatment
Eating disorder treatment had been sought at some time by 
86% of Australian participants and 91% of New Zealand 
participants meeting lifetime AN criteria, with the percent-
ages for each category of treatment shown in Table 4. 
Participants could select as many treatment types as applied 
to them. Over half of the Australian participants meeting 
lifetime AN case criteria (1935; 57%) had received at least 
one of the four most common treatments (general practi-
tioner, dietitian, outpatient treatment or specialised inpa-
tient ward). Access rates for these treatments were higher 
for New Zealand participants meeting lifetime AN case cri-
teria (OR 5.9, 95% CI: [4.5, 7.8]), with 481 (89%) having 
received at least one of the four most common treatments. 
Similar proportions of Australian (584; 17%) and New 
Zealand (93; 17%) participants meeting lifetime AN case 
criteria had received all four of these treatments at some 
time (OR = 1.00, 95% CI: [0.78, 1.27]). At the time of the 
study, 33% of Australian participants and 27% of New 
Zealand meeting lifetime AN case criteria were currently 
under the care of a medical practitioner for eating disorders. 
Significantly more individuals meeting lifetime AN case 
criteria who reported a current BMI < 18.5 kg/m2 (56% in 
Australia; 57% in New Zealand) were under current medi-
cal care for an eating disorder than those with a current 
BMI ⩾ 18.5 kg/m2 (23% in Australia, 19% in New 
Zealand).
Discussion
The present paper describes the characteristics of 3414 
Australian and 543 New Zealand individuals meeting life-
time AN case criteria recruited for a GWAS to help unravel 
the genetic aetiology of AN. This is the largest sample from 
this region yet reported, and the recruitment success is 
likely to reflect the wide variety of study promotion meth-
ods across both conventional and social media platforms, 
and the high level of interest in the study demonstrated by 
those living with AN.
A key feature of this study is that it includes participants 
who met all AN criteria at the time of the study, as well as 
those in partial or full remission. An important interim find-
ing of this study is that only 56% of people with lifetime 
AN with a current BMI less than 18.5 kg/m2 were under the 
care of a medical practitioner for an eating disorder at the 
time of the study. By comparison, a Finnish twin study 
(Keski-Rahkonen et al., 2007) found that approximately 
half of the people in their sample meeting lifetime case cri-
teria had been previously detected in the health care sys-
tem. Although the present study cohort is not 
epidemiologically representative, this result still indicates 
the importance of awareness, detection and intervention 
regarding weight control behaviours, especially given the 
young ages at which behaviours have potential to emerge.
There were few differences between the cohorts 
recruited from Australia and New Zealand. The average 
BMI values for participants at the time of the questionnaire 
were substantially lower than recent population estimates 
for women in both Australia (27.2 kg/m2; 95% CI: [27.0 kg/
m2, 27.4 kg/m2]) (Australian Bureau of Statistics, 2015) 
and New Zealand (28.1 kg/m2; 95% CI: [27.9 kg/m2, 28.4 
kg/m2]) (New Zealand Ministry of Health, 2015). New 
Zealand participants meeting lifetime AN case criteria had 
lower self-reported minimum BMI since age 18 than 
Australian participants, potentially indicating that the aver-
age AN severity in the New Zealand cohort was greater 
than in the Australian cohort. This may have occurred 
through differences in the recruitment strategies (or their 
effectiveness) between the two countries. Rates of ever 
having used particular methods of weight control (diet pills, 
laxatives and diuretics) also differed between the two 
cohorts. Again, this could be due to differences in study 
recruitment. However, it is noteworthy that the only meth-
ods of weight control displaying this difference are ones 
which require purchase of a medication. Therefore, the 
observed usage rate difference may reflect differences in 
availability or acceptance of these methods (now or in the 
past) between Australia and New Zealand.
In common with epidemiological studies (Fisher et al., 
2001), the weight control methods of fasting and exercise 
had the earliest average ages of onset in this study. An 
Australian population-based study previously found driven 
exercise for the purposes of weight control occurring in 
over 50% of girls by the age of 14 years, with fasting occur-
ring in 16% of female study participants of the same age 
(Patton et al., 1999). As in the present study, purging 




Australia (n = 3414) New Zealand (n = 543)
Specialised inpatient 1000 (29.3%) 243 (44.8%)
Nonspecialised inpatient  445 (13.0%) 111 (20.4%)
Residential treatment – 117 (21.5%)
Day hospital treatment programme  448 (13.1%) –
Partial hospitalisation – 107 (19.7%)
Outpatient treatment programmes 1293 (37.8%) –
 Intensive – 211 (38.9%)
 Other – 331 (61.0%)
General practitioner/primary care physician 1546 (45.2%) 248 (45.7%)
Dietitian 1379 (40.4%) 298 (54.9%)
‘–’ Denotes response option not available in that country’s questionnaire.
behaviours became more common in later teenage years, 
although the eating disorder symptom prevalence estimates 
were lower, possibly due to their sample not preferentially 
recruiting participants with AN. A study of New Zealand 
adolescent girls (Fear et al., 1996) aged 14–15 years has 
also previously found self-induced vomiting to be the most 
common purging method among that age group (12%) with 
use of laxatives, diuretics and diet pills being much less 
common (0.2–2.5%).
Treatment provided by general practitioners and dieti-
tians was among the most common types of professional 
treatment received by participants in our study. This high-
lights the importance of providing relevant training to these 
groups in identifying and treating those with eating disor-
ders. The percentage of Australians meeting lifetime AN 
case criteria who had received treatment was lower than 
that observed among New Zealanders meeting the same 
criteria. This could in part be due to geographical differ-
ences, with New Zealand having a higher average popula-
tion density (15.8 people per km2 as compared to 3.1 people 
per km2 in Australia) (Australian Bureau of Statistics, 
2016b; Statistics New Zealand, 2015). However, similarly 
high percentages of the two countries’ populations live in 
urban areas of 1000 or more people (Australian Bureau of 
Statistics, 2001), indicating that some of the differences 
may be due to relative availability of various types of 
services.
Our study has several limitations that should be consid-
ered. First, use of retrospective self-report data rather than 
clinical assessments may have affected the quality and 
accuracy of data collected, particularly with respect to 
recall of anthropometric measurements, age of symptom 
onset and use of weight control measures (Henry et al., 
1994). Self-report height and weight have been previously 
shown to result in overall underestimate of BMI in a com-
munity sample (Fairburn and Beglin, 1994). However, 
studies of women with eating disorders have found that 
participants with AN tend to overestimate their body 
weight (Ciarapica et al., 2010; Meyer et al., 2009). A 
study comparing reporting methods for behavioural fea-
tures of eating disorders found no statistically significant 
differences between interview and self-report measures of 
self-induced vomiting or laxative misuse in an AN patient 
sample, although a difference of marginal clinical signifi-
cance was observed for reporting of laxative misuse in a 
community sample (Fairburn and Beglin, 1994). Second, 
low retention from initial registration to questionnaire 
completion was observed in this sample for prospective 
participants under the age of 18 years, as a result of requir-
ing parental consent for participation. This is likely to 
have resulted in the experiences of younger AN being 
under-represented in the study sample. It is unknown 
whether the low rates of obtaining parental consent are 
due to parental objection to study participation, or young 
individuals being unwilling to discuss the study (and their 
disorder) with their parents; however, it is notable that the 
study participants in this age group nominated ‘family/
friend’ as the most important source of study information. 
Third, this study has a low recruitment rate for male AN 
cases compared to local and international population-
based estimates (Goodman et al., 2014; Hay et al., 2015; 
Qian et al., 2013; Yao et al., 2016). Study recruitment was 
not actively aimed towards males, for whom eating disor-
ders are less well characterised (Strother et al., 2012). 
Fourth, the high percentage of participants who have 
sought eating disorder treatment at some time indicates 
that the sample is likely to be self-selected for treatment 
utilisation and/or severity of illness, as compared with 
population-based studies. Finally, the study recruitment 
methods used may have resulted in disproportionate 
recruitment from some geographical areas or ethnicities. 
Study participation rates from New Zealand and the vari-
ous states and territories in Australia were not uniform, 
despite promotional campaigns being conducted out of 
some of the under-represented regions (e.g. New South 
Wales). Although the proportions of Australian study par-
ticipants nominating non-European ancestries were 
broadly in line with Australian population estimates 
(Khoo et al., 2004), individuals nominating European-
only ancestry may have been over-represented as com-
pared with Australian census data. The New Zealand 
census collects ethnicity data rather than ancestry data; 
however, the results from the 2013 New Zealand Census 
(Statistics New Zealand, 2016a) (in which 61% of the 
population stated they had European-only ethnicity, and a 
further 9% of the population stated they had European 
ethnicity in combination with other ethnicities) indicate 
the potential for over-representation of individuals with 
European-only ancestry in the New Zealand cohort of this 
study as well.
The primary reason for participants not meeting case cri-
teria in this study was self-reporting never having had a BMI 
less than 18.5 kg/m2. DSM-5 criteria for AN (American 
Psychiatric Association, 2013) include a requirement for a 
‘significantly low body weight in the context of age, sex, 
developmental trajectory and physical health’, in recogni-
tion that normal weight range differs among individuals. 
Increasing numbers of individuals presenting with atypical 
AN (where all AN criteria are met except that significant 
weight loss has still resulted in a weight that is within or 
above normal range) have been noted in clinical practice 
(Sawyer et al., 2016), with findings that individuals with 
atypical AN may have physical and psychological morbidity 
as severe as individuals with full-threshold AN (Whitelaw 
et al., 2014). Recent research (Fairweather-Schmidt and 
Wade, 2014) has suggested that threshold eating disorders 
(AN, BN and binge-eating disorder) and other specified 
feeding and eating disorders (OSFED, including atypical 
AN) share a common genetic basis but possibly separate 
environmental influences. Further investigation of the 
aetiology of both AN and atypical AN is warranted (Hay 
et al., 2008; Sawyer et al., 2016). With the prevalence of eat-
ing disorders in Australia known to be increasing (Hay et al., 
2008; Goodman et al., 2014), it is clear that continuing 
research into the causes of AN (e.g. ANGI) in the Australasian 
and international context is of significant importance.
Conclusion
This study has collated the largest sample of individuals 
with lifetime AN in Australasia to date, with the overarch-
ing purpose of finding genes which influence this severe 
disorder. Key findings relate to characteristics of lifetime 
AN in Australia and New Zealand, e.g., treatment-utilisa-
tion behaviours and age of onset of weight control behav-
iours. The study provides useful information relating to 
recruitment from the general population of eating disorder 
cases for GWAS and related studies.
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